4.7 Article

Mycobacterium tuberculosis Peptidyl Prolyl Isomerase A Interacts With Host Integrin Receptor to Exacerbate Disease Progression

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 224, 期 8, 页码 1383-1393

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiab081

关键词

tuberculosis; virulence; secretion; PPiA; chaperone; integrin; matrix metalloproteinases

资金

  1. JC Bose fellowship [SB/S2/JCB-012/2015, JCB/2019/000015]
  2. Indian Council of Medical Research, Senior Research Fellowship
  3. D. S. Kothari postdoctoral fellowship
  4. Science and Engineering Research Board
  5. Tuberculosis Aerosol Challenge Facility at International Centre for Genetic Engineering and Biotechnology

向作者/读者索取更多资源

PPiA not only assists in the survival of Mtb but also promotes disease progression by affecting host cell status through interaction with host-related factors.
Attenuated intracellular survival of Mycobacterium tuberculosis (Mtb) secretory gene mutants exemplifies their role as virulence factors. Mtb peptidyl prolyl isomerase A (PPiA) assists in protein folding through cis/trans isomerization of prolyl bonds. Here, we show that PPiA abets Mtb survival and aids in disease progression by exploiting host-associated factors. While the deletion of PPiA has no discernable effect on bacillary survival in a murine infection model, it compromises the formation of granuloma-like lesions and promotes host cell death through ferroptosis. Overexpression of PPiA enhances the bacillary load and exacerbates pathology in mice lungs. Importantly, PPiA interacts with the integrin alpha 5 beta 1 receptor through a conserved surface-exposed RGD motif. The secretion of PPiA as well as interaction with integrin contributes to disease progression by upregulating multiple host matrix metalloproteinases. Collectively, we identified a novel nonchaperone role of PPiA that is critical in facilitating host-pathogen interaction and ensuing disease progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据